Mukka Proteins– Are you looking for Mukka Proteins IPO GMP / Grey Market Premium and Kostak rate? You are at the right place, here you will get the latest Mukka Proteins IPO GMP live.
The public issue of Mukka Proteins will open on February 29, 2024 and remain open until March 04, 2024 for bidding. It has set the price band at approximately approximately ₹26 to ₹28 per equity share and expects to raise ₹224.00 crore.
Ahead of Mukka Proteins opening date, grey market indicators are pointing to positive developments.
Mukka Proteins IPO GMP
Mukka Proteins Grey Market Premium (GMP) is currently at ₹35 , indicating the demand for the company's shares in the unofficial market.
Mukka Proteins IPO price band
The price band for Mukka Proteins initial public offering (IPO) has been set at ₹26 to ₹28 per equity share, offering potential investors a range within which they can place their bids.
Mukka Proteins IPO date
Starting from February 29, 2024, the IPO will be open for bidders to participate, and it will remain open until March 4, 2024, providing a limited window for interested parties to take part in the offering.
Mukka Proteins IPO size
With an ambitious goal of raising ₹224.00 Crores, Mukka Proteins is poised to make a significant impact in the financial markets through its IPO.
Mukka Proteins IPO lot size
Investors can apply for the IPO in lots, with each lot comprising 535 shares, allowing them to tailor their investment based on their financial capacity and strategic objectives.
Mukka Proteins IPO application limit
The application limit for the IPO is set at a minimum of 13 lot for bidders, while retail investors have the opportunity to apply for up to 1 lots, offering flexibility in participation.
Mukka Proteins IPO allotment date
The tentative schedule for the allotment of Mukka Proteins IPO shares is March 05, 2024, providing a timeline for successful bidders to receive their allocated shares.
Mukka Proteins IPO listing
Mukka Proteins aims to list its shares on March 07, 2024, subject to market conditions, with plans to list on both the BSE and NSE, signaling a significant milestone for the company.
Mukka Proteins IPO registrar
Cameo Corporate Services Limited has been entrusted with the crucial role of serving as the registrar for Mukka Proteins, ensuring a smooth and efficient process for all stakeholders involved.
Investors and market analysts are closely monitoring the developments surrounding Mukka Proteins IPO, as it presents an opportunity to gauge the market's response to the company's offering. The subscription data and final oversubscription figures will provide valuable insights into the demand for AIK Pipes And Polymers's shares and the overall investor sentiment.
Mukka Proteins IPO is generating considerable interest due to the company's strong presence in the engineering and design services sector, as well as its diverse client base spanning various industries. Additionally, the IPO's performance will be indicative of investor confidence in the broader economic outlook and the attractiveness of the Indian capital markets.
As the IPO progresses through its various stages, prospective investors will closely analyze factors such as the company's financial performance, growth prospects, and competitive positioning to make informed decisions about participating in the offering. This heightened interest is expected to contribute to robust trading activity following the listing of Mukka Proteins shares.
The successful execution of Mukka Proteins IPO is anticipated to further bolster the company's financial position and provide funds for strategic initiatives, expansion plans, and potential acquisitions. Moreover, it will offer an opportunity for retail investors, institutional investors, and other market participants to gain exposure to a prominent player in the engineering and design services sector.
Overall, Mukka Proteins IPO is poised to make a significant impact on the Indian markets, and its outcome will be closely observed as a barometer of investor confidence and market dynamics.